MPS Pharmaa Limited has filed its mandatory quarterly investor complaint statement with BSE Limited for the quarter ended 31st March, 2026, reporting a clean record with zero complaints across all categories. The pharmaceutical company, formerly known as Advik Laboratories Limited, submitted the disclosure in compliance with Regulation 13(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Quarterly Complaint Summary

The company's investor complaint statement for Q4FY26 demonstrates complete absence of grievances from shareholders during the reporting period:

Regulatory Compliance

The statement was formally submitted to BSE Limited on 13th April, 2026, and was digitally signed by Company Secretary Pooja Chuni. The disclosure fulfills the company's obligation under SEBI regulations to maintain transparency regarding investor grievances and complaint resolution mechanisms.

Company Details

MPS Pharmaa Limited operates under BSE Scrip Code 531686 and ASE Scrip Code 01636. The company maintains its corporate office at Arunachal Building, Barakhamba Road, Connaught Place, New Delhi, while its registered office and manufacturing facility are located in the Roz-Ka-Meo Industrial Area, Sohna, Haryana.

The zero complaint record for Q4FY26 indicates effective investor relations management and suggests minimal shareholder concerns during the quarter. This regulatory filing demonstrates the company's commitment to maintaining transparent communication with stakeholders and adhering to prescribed disclosure norms.

MPS Limited has submitted its quarterly compliance certificate to stock exchanges, fulfilling regulatory requirements under SEBI's depositories regulations for the quarter ended 31 March 2026. The IT services company filed the mandatory certificate on 06 April 2026 with both NSE and BSE.

Regulatory Compliance Filing

The certificate submission relates to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. MPS Limited's Company Secretary and Compliance Officer Raman Sapra signed and submitted the documentation to ensure regulatory compliance.

Registrar Confirmation

Cameo Corporate Services Limited, serving as MPS Limited's Registrar and Share Transfer Agent, issued the certificate on 03 April 2026. The registrar confirmed proper handling of securities dematerialisation processes during the quarter.

The certificate validates that:

• Securities received from depository participants for dematerialisation were properly confirmed to depositories
• All securities have been listed on stock exchanges where earlier issued securities are traded
• Security certificates received for dematerialisation were mutilated and cancelled after verification
• Depository names were substituted in the register of members within stipulated time limits

Stock Exchange Communication

MPS Limited communicated with both major Indian stock exchanges for this filing. The company trades on NSE under the symbol MPSLTD and on BSE with scrip code 532440.

This quarterly filing represents standard regulatory compliance for listed companies, ensuring transparency in depository operations and securities handling procedures. The timely submission demonstrates MPS Limited's commitment to maintaining proper corporate governance standards.